COLSTAR
LIVE

Serial Number

79333840

Owner

BIOFARMA

Attorney

Maury M. Tepper, III

Filing Date

Dec 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

COLSTAR Trademark

Serial Number: 79333840 • Registration: 7028321

COLSTAR is a trademark filed by BIOFARMA on December 22, 2021. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BIOFARMA (296 trademarks)

50, rue Carnot
Suresnes cedex 92284 , FR

Entity Type: 03

Trademark Details

Filing Date

December 22, 2021

Registration Date

April 18, 2023

Published for Opposition

January 31, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 21, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 2, 2023 FICS
FINAL DISPOSITION PROCESSED
Aug 1, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 18, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 18, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Feb 1, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 31, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 11, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 11, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 11, 2023 NONP
REFUSAL PROCESSED BY IB
Dec 29, 2022 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 23, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 8, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 8, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 28, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 27, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 23, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 17, 2022 REPR